NAYA
Price
$2.20
Change
+$0.21 (+10.55%)
Updated
Apr 2 closing price
Capitalization
1.3M
RANI
Price
$1.39
Change
+$0.16 (+13.01%)
Updated
Apr 2 closing price
Capitalization
46.3M
34 days until earnings call
Ad is loading...

NAYA vs RANI

Header iconNAYA vs RANI Comparison
Open Charts NAYA vs RANIBanner chart's image
NAYA Biosciences
Price$2.20
Change+$0.21 (+10.55%)
Volume$74.92K
Capitalization1.3M
Rani Therapeutics Holdings
Price$1.39
Change+$0.16 (+13.01%)
Volume$185.88K
Capitalization46.3M
NAYA vs RANI Comparison Chart
Loading...
NAYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NAYA vs. RANI commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NAYA is a Hold and RANI is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (NAYA: $2.20 vs. RANI: $1.39)
Brand notoriety: NAYA and RANI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NAYA: 245% vs. RANI: 17%
Market capitalization -- NAYA: $1.3M vs. RANI: $46.3M
NAYA [@Biotechnology] is valued at $1.3M. RANI’s [@Biotechnology] market capitalization is $46.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NAYA’s FA Score shows that 0 FA rating(s) are green whileRANI’s FA Score has 0 green FA rating(s).

  • NAYA’s FA Score: 0 green, 5 red.
  • RANI’s FA Score: 0 green, 5 red.
According to our system of comparison, NAYA is a better buy in the long-term than RANI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NAYA’s TA Score shows that 5 TA indicator(s) are bullish while RANI’s TA Score has 4 bullish TA indicator(s).

  • NAYA’s TA Score: 5 bullish, 3 bearish.
  • RANI’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, NAYA is a better buy in the short-term than RANI.

Price Growth

NAYA (@Biotechnology) experienced а -11.29% price change this week, while RANI (@Biotechnology) price change was -2.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.26%. For the same industry, the average monthly price growth was -7.43%, and the average quarterly price growth was -11.99%.

Reported Earning Dates

RANI is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-5.26% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RANI($46.3M) has a higher market cap than NAYA($1.3M). RANI YTD gains are higher at: 1.460 vs. NAYA (-77.366). NAYA has higher annual earnings (EBITDA): -5.58M vs. RANI (-48.72M). RANI has more cash in the bank: 30.4M vs. NAYA (472K). NAYA has less debt than RANI: NAYA (5.34M) vs RANI (33.7M). NAYA has higher revenues than RANI: NAYA (6.23M) vs RANI (0).
NAYARANINAYA / RANI
Capitalization1.3M46.3M3%
EBITDA-5.58M-48.72M11%
Gain YTD-77.3661.460-5,300%
P/E Ratio1.30N/A-
Revenue6.23M0-
Total Cash472K30.4M2%
Total Debt5.34M33.7M16%
FUNDAMENTALS RATINGS
NAYA: Fundamental Ratings
NAYA
OUTLOOK RATING
1..100
79
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
98
P/E GROWTH RATING
1..100
38
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NAYARANI
RSI
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 14 days ago
83%
Bullish Trend 14 days ago
84%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
NAYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HOG25.580.52
+2.08%
Harley-Davidson
STEM0.34N/A
+1.36%
Stem
IMKTA65.640.49
+0.75%
Ingles Markets
CMG52.020.35
+0.68%
Chipotle Mexican Grill
CENN0.83-0.01
-1.21%
Cenntro

NAYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAYA has been loosely correlated with VNDA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if NAYA jumps, then VNDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAYA
1D Price
Change %
NAYA100%
+10.55%
VNDA - NAYA
36%
Loosely correlated
+0.22%
RANI - NAYA
28%
Poorly correlated
+13.01%
KPTI - NAYA
27%
Poorly correlated
+14.69%
SSKN - NAYA
25%
Poorly correlated
-1.12%
VYNE - NAYA
25%
Poorly correlated
+7.19%
More

RANI and

Correlation & Price change

A.I.dvisor tells us that RANI and DRUG have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RANI and DRUG's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RANI
1D Price
Change %
RANI100%
+13.01%
DRUG - RANI
31%
Poorly correlated
-2.22%
UBX - RANI
31%
Poorly correlated
+10.41%
BDTX - RANI
28%
Poorly correlated
+6.04%
NAYA - RANI
28%
Poorly correlated
+10.55%
FATE - RANI
28%
Poorly correlated
+1.70%
More